1. 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial. Issue 3 (March 2021) Authors: Hoskin, Peter; Popova, Biliana; Schofield, Oliver; Brammer, Caroline; Robinson, Martin; Brunt, A Murray; Madhavan, Krishnaswamy; Illidge, Tim; Gallop-Evans, Eve; Syndikus, Isabel; Clifton-Hadley, Laura; Kirkwood, Amy A Journal: Lancet oncology Issue: Volume 22:Issue 3(2021) Page Start: 332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A novel approach to low dose total skin electron beam therapy (TSEBT). (September 2018) Authors: Suhail, Taqdees; Parry, Eileen; Bolton, Steve; Poole, Alistair; Illidge, Tim; Cowan, Richard Journal: European journal of cancer Issue: Volume 101(2018)Supplement 1 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma. Issue 3 (March 2015) Authors: Illidge, Tim; Bouabdallah, Reda; Chen, Robert; Gopal, Ajay K.; Moskowitz, Craig H.; Ramchandren, Radhakrishnan; Shustov, Andrei R.; Tilly, Herve; Trippett, Tanya M.; Gibb, Adam; Grove, Laurie E.; Advani, Ranjana Journal: Leukemia & lymphoma Issue: Volume 56:Issue 3(2015:Mar.) Page Start: 703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study. (16th October 2017) Authors: Bröckelmann, Paul J.; Zagadailov, Erin A.; Corman, Shelby L.; Chirikov, Viktor; Johnson, Courtney; Macahilig, Cynthia; Seal, Brian; Dalal, Mehul R.; Illidge, Tim Journal: European journal of haematology Issue: Volume 99:Number 6(2017) Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Issue 10168 (19th January 2019) Authors: Horwitz, Steven; O'Connor, Owen A; Pro, Barbara; Illidge, Tim; Fanale, Michelle; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob Haaber; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Feldman, Tatyana; Lennard, Anne; Belada, David; Illés, Árpád; Tobinai, Kense... Journal: Lancet Issue: Volume 393:Issue 10168(2019) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comment on: "Clinical Features, Management, and Prognosis of an International Series of 161 Patients With Limited-Stage Diffuse Large B-Cell Lymphoma of the Bone (the IELSG-14 Study)". (23rd October 2014) Authors: Hoppe, Richard; Illidge, Tim; Specht, Lena; Vogelius, Ivan; Yahalom, Joachim Journal: Oncologist Issue: Volume 19:Number 12(2014) Page Start: 1289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Comment on: "Clinical Features, Management, and Prognosis of an International Series of 161 Patients With Limited‐Stage Diffuse Large B‐Cell Lymphoma of the Bone (the IELSG‐14 Study)". (23rd October 2014) Authors: Hoppe, Richard; Illidge, Tim; Specht, Lena; Vogelius, Ivan; Yahalom, Joachim Journal: Oncologist Issue: Volume 19:Number 12(2014) Page Start: 1289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. Issue 1 (9th March 2020) Authors: Galluzzi, Lorenzo; Vitale, Ilio; Warren, Sarah; Adjemian, Sandy; Agostinis, Patrizia; Martinez, Aitziber Buqué; Chan, Timothy A; Coukos, George; Demaria, Sandra; Deutsch, Eric; Draganov, Dobrin; Edelson, Richard L; Formenti, Silvia C; Fucikova, Jitka; Gabriele, Lucia; Gaipl, Udo S; Gameiro, Sofia... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant. Issue 11 (November 2013) Authors: Arai, Sally; Fanale, Michelle; deVos, Sven; Engert, Andreas; Illidge, Tim; Borchmann, Peter; Younes, Anas; Morschhauser, Franck; McMillan, Alex; Horning, Sandra J. Journal: Leukemia & lymphoma Issue: Volume 54:Issue 11(2013:Nov.) Page Start: 2531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma. (1st October 2013) Authors: Collins, Graham P.; Parker, Anne N.; Pocock, Christopher; Kayani, Irfan; Sureda, Anna; Illidge, Tim; Ardeshna, Kirit; Linch, David C.; Peggs, Karl S. Journal: British journal of haematology Issue: Volume 164:Number 1(2014:Jan.) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗